Characterization of the Microbiome in Cutaneous T Cell Lymphoma
ConditionCutaneous T Cell Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorNorthwestern University
About this trial
Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.
Eligibility criteria
Qualifiers
Group 1: Patients with stage IA-IIA cutaneous T cell lymphoma
Group 2: Patients with stage IIB and above cutaneous T cell lymphoma
Group 3: Patients with CD30+ lymphoproliferative disorder including lymphomatoid papulosis and cutaneous anaplastic large cell lymphoma
Group 4: Patients with plaque psoriasis with BSA>5% on routine phototherapy per standard of care
Disqualifiers
All Groups: Subjects who are younger than 18 years of age or older than 90 years of age
All Groups: Subjects who are unable to give consent
Patients currently on systemic antibiotics or recent (within past 4 weeks) exposure to systemic antibiotics
We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 6 trial groups6
Trial groupsSee each trial group below.
Sponsors and collaborators
Source ClinicalTrials.gov